Prostate-specific antigen progression predicts overall survival in patients with metastatic prostate cancer: Data from Southwest Oncology Group trials 9346 (intergroup study 0162) and 9916
- Maha H.A. Hussain
- , Bryan Goldman
- , Cathy Tangen
- , Celestia S. Higano
- , Daniel P. Petrylak
- , George Wilding
- , Atif M. Akdas
- , Eric J. Small
- , Bryan J. Donnelly
- , Subramanian Kanaga Sundram
- , Patrick A. Burch
- , Robert S. DiPaola
- , E. David Crawford
Producción científica: Article › revisión exhaustiva
192
Citas
(Scopus)